Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor
Clinical trial NCT01896284 · COMPLETED
Trial details
- NCT number
- NCT01896284
- Sponsor
- Barcelona Macula Foundation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2014-11-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.